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Abstract
Introduction: Tn polyagglutination syndrome is a rare disorder that has been reported on only a few occasions in
the literature, and, to the best of our knowledge, never before in the context of febrile neutropenia.
Case presentation: We report the case of a 26-year-old Caucasian woman who presented to our emergency
department complaining of a persistent fever over the previous three days. She had a history of long-standing
refractory pancytopenia with multi-lineage dysplasia and severe neutropenia, but she had rarely experienced
infection. The results of a physical examination and multiple laboratory tests were unremarkable. While
investigating the possible causes of the refractory, long-standing pancytopenia, the possibility of a polyagglutinable
state was suggested. Blood samples were sent to the laboratory for an analysis of mixed-field seed lectin
agglutination assay. A serum lectin panel confirmed the final diagnosis of Tn-activation.
Conclusions: We should include Tn-activation in our differential whenever we encounter cases of refractory long-
standing idiopathic cytopenias and inconclusive bone marrow results displaying multi-lineage dysplasia. Novel
genetic techniques have recently revealed the interesting pathophysiology of this phenomenon. The recognition
and inclusion of Tn polyagglutination syndrome in our differential diagnoses has important clinical implications,
given its main associated features, such as severe thrombocytopenia and neutropenia, which are usually linked to
a benign clinical course and prognosis. Increased awareness of the polyagglutinable disorders will potentially
decrease the need for invasive and costly medical interventions and also raises the need for monitoring of this
specific sub-set of patients. In addition, the study of the expression and implications of Tn, and other similar
antigens, offers a fascinating perspective for the study of its role in the diagnosis, prognosis and immunotherapy of
solid tumors and hematological malignancies. The infrequency with which Tn polyagglutination syndrome is
encountered, its clinical features and its pathophysiology make it a formidable diagnostic challenge.
Introduction
During an initial assessment of patients with unex-
plained neutropenia, clinicians should include Tn poly-
agglutination syndrome (TnP) in their differential
diagnoses. Many cases remain undiagnosed due to a
lack of knowledge about this entity, its implications and
its pathophysiology. Our case report is intended to
increase awareness of this diagnosis. We report the case
of a patient with persistent TnP and undertake a concise
review of the literature regarding this condition.
Case presentation
A 26-year-old Caucasian woman presented to our emer-
gency department complaining of a persistent fever
(ranging between 38.5°C and 40°C) over the previous
three days. She had been in her usual state of health
until this time. She also complained of palpitations,
chills and diaphoresis. She denied any other symptoms.
She described no known contact with sick individuals,
no trauma, insect bites or any history of travel.
She was born full term to a 24-year-old mother via
vaginal delivery, weighing 7 lbs 3oz. At three-weeks of
age, she developed diffuse petechiae which persisted and,
after multiple studies, she was diagnosed as having a
long-standing refractory pancytopenia with multi-lineage
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blood cell (WBC) count of 1.5×10
3 cells per mm
3 with
severe neutropenia, with an approximate absolute neu-
trophil count (ANC) in the 400 range. Her hemoglobin
level was 8 g/dL and her platelet count was approxi-
mately 45×10
3/mm
3. Despite her condition, she had an
infrequent history of infections. These included otitis
media and adenitis at eight months of age, Staphylococcal
cellulitis at 15 months and two instances of uncompli-
cated pyelonephritis at ages 15 and 21 which were treated
successfully with amoxicillin and gatifloxacin. She had
two uneventful pregnancies and a third which was com-
plicated by severe pre-eclampsia. She noted occasional
petechiae and some bruising, but had not had any serious
hemorrhages. Please refer to Figure 1 for a graphic
description outlining the 10-year span blood count num-
bers for this patient.
She has had a bone marrow biopsy performed every
two years as a follow-up procedure for her refractory
pancytopenia, and no clear etiology has been defined.
This lack of diagnostic certainty and her ongoing con-
cerns regarding her future health and that of her chil-
dren has caused her major distress. She has also been
told by some physicians that she and her family may
carry an increased risk for hematological malignancies.
On physical examination, she was febrile with a tem-
perature of 38.3°C. Her heart rate was 105 beats per min-
ute, her blood pressure was 115/82 mmHg and her
respiratory rate was 17 breaths per minute with an oxy-
gen saturation of 99 percent at room air. Her physical
examination was unremarkable except for sinus tachycar-
dia. On her admission to our hospital, our laboratory stu-
dies showed a WBC count of 1.53×10
3 cells per mm
3
with 20 percent neutrophils and 66 percent lymphocytes.
Her ANC was 400, her hemoglobin level was 6.8 g/dL,
her Mean Corpuscular Volume was 82 fL and her platelet
count was 47×10
3/mm
3. Her electrolytes were within
normal range. Her prothrombin time was 19.1 seconds,
and the International Normalized Ratio -INR- was 1.1.
She was diagnosed with febrile neutropenia and she
was started on empiric IV piperacillin/tazobactam after
we obtained blood and urine cultures. A computed
tomography (CT) scan of her chest, paranasal sinuses,
abdomen and pelvis were ordered to evaluate the source
of the fever. All the imaging studies showed no
abnormalities.
Figure 1 Complete blood count levels. Units: WBC (×10
1 cells per mm
3); Hb (g/dL); Platelets (×10
3 cells per mm
3).
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low. After the ingestion of an oral contrast, she devel-
oped soft stools which prompted us to undertake stool
studies. These were negative for lactoferrin, Clostridium
difficile and fecal leukocytes. Assessment for ova and
parasites as well as a stool culture were also negative.
A direct Coombs test was negative, her reticulocyte
count was 0.2 percent, and an iron study panel revealed
serum iron levels of 7 mmol/L, ferritin 72 ug/L, and
iron saturation levels of four percent. Her lactate dehy-
drogenase and bilirubin levels were unremarkable.
She continued to spike fevers overnight with no evi-
dent source of infection. A bone marrow biopsy was
completed, suggesting once again the diagnosis of
refractory pancytopenia with multi-lineage dysplasia. No
increased blasts were noted. Fluorescent in situ hybridi-
zation (FISH), flow cytometry and cytogenetics did not
reveal any major abnormalities. While investigating pos-
sible causes of the refractory, long-standing pancytope-
nia, the possibility of a polyagglutinable state was
suggested. Blood samples were sent to the laboratory for
an analysis of mixed-field seed lectin agglutination assay.
A serum lectin panel confirmed the final diagnosis of
Tn-activation (Dolichos biflorus +, Glycine soja +, Salvia
sclerea +) and TnP was diagnosed. She responded to
treatment very well and after 48 hours of being afebrile,
s h ew a sd i s c h a r g e dw i t haf i v ed a yc o u r s eo fc e f p o d o x -
ime. Her samples were sent for Tn monoclonal antibody
immunochemistry which reconfirmed her diagnosis.
TnP is a rare disorder that has been reported on only
six occasions in the medical literature and never before
in the setting of febrile neutropenia. TnP is an acquired
disorder, characterized by the defective biosynthesis of
red blood cell (RBC) membrane glycoproteins that results
in the exposure of normally cryptic N-acetylgalctosamine
residues (GalNAc) [1,2].
Polyagglutination is the term applied to RBC that are
agglutinated by almost all samples of human sera from
adults, but not by autologous serum or sera of newborns
[1-3] (Figure 2). Previously, all cases of TnP, and many
other polyagglutinable phenomenons, were diagnosed
during infancy or at the moment when a blood group
classification for a transfusion was made, as former
techniques of hemoclassification were performed using
human adult serum containing multiple antibodies.
However, current blood grouping practice uses murine
diluted monoclonal antibody re-agents that do not
include any other potentially pro-agglutinating immuno-
globulins (Ig), thus denying the opportunity to recognize
polyagglutinable cells and their implications [4,5]. This
has been reflected in a lack of reports about this condi-
tion over the last 30 years.
Tn RBC are polyagglutinable because most adult sera
contain naturally occurring anti-Tn. T and Tn antigens
(from Hiibener-Thomsen-Friedenreich) are normally
inaccessible to the immune system. These antibodies
occur primarily due to the exposure to the intestinal
flora, where highly immunogenic T and Tn-specific
structures are present in most Enterobacteriaceae [1-4].
The Tn defect can also be found on the membranes of
platelets, granulocytes and lymphocytes [6]. The first
example of TnP was encountered in a patient with
hemolytic anemia, and many of the other cases observed
since then have revealed a common association with
leukopenia and thrombocytopenia [7].
Tn antigen is caused by a hemizygous pleiotropic
somatic mutation or gene suppression in adults at the
pluripotent stem cell level, creating an abnormal clone
in expansion through an autoimmune process, in which
it is hypothesized that the patient’s Natural Killer cells
(NK) target the O-glycans of the normal blood cells and
selectively destroy the normal blood cell population.
This leads to the loss of anti-Tn and possibly the multi-
lineage dysplasia and subsequent cytopenias [8].
Further studies have shown that TnP results from the
inactivation of C1GALT1C1, a gene located at Xq24,
which encodes a chaperone required for the correct
functioning of T-synthase (syn.Gal-b-1-3transferase), a
k e ye n z y m ei nt h es y n t h e s i so fO - g l y c a n s .T h i sr e s u l t s
in the exposure of GalNAc-linked to serine or threonine
on polypeptide backbones, exposing the otherwise cryp-
tic Tn antigen to the erythrocyte surface [8].
A diagnosis of TnP is made using mixed-field seed
lectin agglutination. Lectin typing reagents contain pro-
teins that recognize specific carbohydrates on RBC
membranes, causing their direct agglutination. Positive
agglutination reactions following exposure of the
patient’s red blood cells to specific lectins derived from
seeds of Dolichos biflorus, Glycine soja and Salvia
sclerea plant species are considered as pathognomonic
for diagnosis (Table 1). The only exception occurs in
patients with blood group A, due to its chemical similar-
ity with the Tn antigen [1-5,9]; monoclonal anti-Tn
reagents are available for these cases [9]. Many other
types of agglutination have been described in the litera-
ture. Most of them are transient and related to episodes
of acute infection where bacterial enzymes (for example,
neuraminidase and endob-galactosidase) expose such
antigens (T, Th, Tk, TX, VA). There are some other
inherited types of agglutination whose frequency has not
been established (Cad [Sda], HEMPAS, NOR, Hyde
Park, Tr) [9-11].
TnP is not directly linked to malignancy or an
increased risk of invasive infections, with many reports
of elderly Tn individuals in apparently good health.
However, the Tn antigen itself has been widely studied
as a marker of tumor cells: O-glycans are common con-
stituents of membranes and secreted mucins and an
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many carcinomas [3].
Conclusions
To the best of our knowledge, this is the first report of
TnP in the context of febrile neutropenia. The recognition
of TnP has important clinical implications, because of
its benign natural history. An awareness of this fact
decreases the need for invasive and costly medical
interventions, even though close monitoring is advised
i nt h ee v e n to fs u r g e r yt oa v o id major complications.
As a teaching point, we should include this diagnosis
in our differential whenever we encounter a diagnosis
of refractory long-standing idiopathic cytopenia and
inconclusive bone marrow results displaying multi-
lineage dysplasia. The management of this condition is
conservative. Blood count levels should be obtained
e v e r y6t o1 2m o n t h s ,a n dab o n em a r r o wb i o p s yi s
warranted if there is a significant change in
the baseline numbers, frequent fevers, infections or
hemorrhagic events.
No additional measures are required for patients with
TnP during a blood product transfusion. The passive
transfer of anti-Tn is unlikely to be hazardous because
donor anti-Tn would be diluted with anti-coagulant,
and IgM is unlikely to cause in vivo hemolysis. It is also
clear that TnP patients should not be candidates for
blood donation [1,12].
Figure 2 RBC polyagglutination. Peripheral smear displaying polyagglutination phenomenon.
Table 1 Mixed field polyagglutination reactions with
specific seed lectins
Mixed field polyagglutination reactions with specific seed lectins
T Tn Th Tk Tx Hyde
Park
VA Cad NOR
Leonurus cardiaca -- - -- - - + -
Dolichos biflorus -+ - - - - - + -
Glycine soja + + - - - +/- - + -
Vicia cretia + - + - - Weak - - -
Griffonia
simplicifolla II
-- -+- + - - -
Arachis hypogaea + - + + + Weak - - -
Salvia sclerea -+ - - - - - - -
Salvia horminum -+ - - - - - - -
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clinical features and its pathophysiology makes it a for-
midable diagnostic challenge.
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